Post

Reuters
@reuters.com

Merck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40% reut.rs/4dRUKdJ

reut.rsMerck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40%An mRNA cancer vaccine developed by Moderna and Merck in combination with a widely ​used immunotherapy cut the risk of death ‌or recurrence of melanoma by 42% and disease spread by 38%, according to data from a large ​trial, potentially paving the way for a ​new era of personalized treatment.

20 reposts79 likes